A view of BYD's nucleic acid testing vehicles. Photo: Courtesy of BYD

Chinese electric vehicle maker BYD, along with biotech firm BGI Group's MGI Tech, have launched a pure electronic nucleic acid testing vehicle that aligns to P2+ biosafety lab. The vehicle is able to complete 20,000 sample tests a day, providing results in two hours at the soonest, according to a statement BYD sent to the Global Times on Wednesday. 

The testing vehicle is developed based on BYD's 12-meter-long low-floor city bus platform. The on-board battery can supply power for the vehicle itself and all on-board equipment, and is able to work independently for more than 10 hours without connecting to an external power supply. 

BYD said the vehicle could save both space and human cost, enabling speed and mobility while providing efficient, comfortable and convenient nucleic acid testing service amid the recent sporadic resurgence of coronavirus cases in north China.

"The vehicle could be placed in businesses, schools, communities, hotels, airports, ports and other ports of entry and exit," BYD said, noting that the vehicle is a combination of green tech with medical service that will contribute to China's anti-coronavirus efforts.

Global Times